There is no universal age or duration at which you must stop hormone therapy. The Menopause Society’s current position is that HRT does not need to be routinely discontinued at age 60 or 65, and the decision should be based on your individual symptoms, health risks, and goals rather than an arbitrary cutoff. That said, the calculus does shift over time, and understanding what changes when you stop can help you and your provider make a well-timed decision.
What the Guidelines Actually Say
For most healthy women who start HRT before age 60, or within 10 years of menopause, the benefits clearly outweigh the risks. Beyond that window, the picture gets more nuanced. The Menopause Society recommends periodic reevaluation of your personal benefit-risk profile, factoring in your age, how long you’ve been on therapy, the type and dose you use, and whether you still have symptoms worth treating.
For women over 65 who still have significant hot flashes, night sweats, or quality-of-life concerns, continuing HRT remains an option after a careful conversation with a provider. The same applies if you’re using HRT to prevent osteoporosis and don’t have a good alternative. The guideline language is deliberately open-ended: there’s no hard stop date, because the evidence doesn’t support one.
Reasons You Might Consider Stopping
The most common reasons women stop HRT include symptoms resolving on their own, reaching an age where they feel less comfortable with the risks, or developing a new health condition that changes the equation. A personal history of or new diagnosis of breast cancer is a clear reason to stop estrogen-progestogen therapy in most cases. Blood clots, stroke, or certain liver conditions also shift the balance.
If you started HRT primarily for hot flashes and night sweats, keep in mind that these symptoms do fade for many women over time, though the timeline varies widely. Some women have vasomotor symptoms for just a few years around menopause. Others deal with them for a decade or more. Periodically reassessing whether your symptoms are still present, perhaps by briefly lowering your dose, can help you gauge whether you still need therapy.
What Happens to Breast Cancer Risk
Breast cancer risk is the concern that drives most conversations about stopping. The answer depends on how long you’ve been on therapy and what type you use. Research from the large French E3N cohort found that when HRT is used for fewer than five years, any excess breast cancer risk disappears within five years of stopping. But for women who used it longer than five years, the elevated risk did not fully dissipate in the five years after cessation.
The type of therapy matters significantly. Estrogen alone (for women who’ve had a hysterectomy) carries a different profile than combination therapy. A large study of Medicare-age women found that estrogen monotherapy used beyond age 65 was actually associated with a 16% lower risk of breast cancer compared to never using it. Combination therapy with a synthetic progestogen, by contrast, was linked to a 10% to 19% increase in breast cancer risk, though this could be reduced by using low-dose transdermal or vaginal preparations. If you’re weighing whether to continue, the specific formulation you’re on is a critical part of the conversation.
Bone and Heart Health After Stopping
HRT is one of the most effective ways to maintain bone density after menopause, and stopping it does reverse that protection. Bone loss resumes once you discontinue therapy, which is worth factoring in if you have osteoporosis or are at high risk for fractures. If bone protection is a primary reason you’re on HRT, your provider may recommend a bone density scan before stopping and potentially transitioning you to a different medication that preserves bone.
On the cardiovascular side, stopping HRT causes measurable changes in cholesterol. In one study, women who discontinued therapy saw their LDL (“bad”) cholesterol rise by an average of 22 mg/dL, compared to less than 4 mg/dL in women who continued. Total cholesterol followed a similar pattern. The encouraging finding: a structured lifestyle intervention involving diet and exercise successfully blunted those increases. So if you do stop, paying attention to diet, physical activity, and cholesterol levels in the months that follow is a practical way to protect your heart.
Symptoms Will Likely Return, at Least Temporarily
This is the part many women aren’t prepared for. In a Swedish population study, 87% of women who had hot flashes before starting HRT experienced their return after stopping. The silver lining: the recurring symptoms were generally reported as less frequent and less bothersome than they were originally. Your body has continued to adjust during the years you were on therapy, even though HRT was masking the symptoms.
How long these returning symptoms last varies. For some women it’s a few months; for others it can stretch longer. Knowing this in advance helps you plan, whether that means timing your discontinuation for a lower-stress period of life or having a backup strategy in place.
Tapering vs. Stopping All at Once
You’ll find strong opinions on both sides of this, but the clinical evidence is surprisingly neutral. Randomized trials comparing abrupt cessation to gradual tapering found no difference in the rate of symptom recurrence at one year. A survey of women veterans did find that tapering was associated with fewer menopausal symptoms after stopping, but those same women were actually more likely to go back on HRT, suggesting the gradual process may have made it harder to commit to quitting.
No optimal tapering schedule has been identified. Some providers suggest reducing the dose over several weeks, others over several months, and others recommend alternating days. If you prefer the psychological comfort of easing off gradually, there’s no harm in it. But if you’d rather stop cleanly and deal with whatever symptoms arise, the evidence suggests you’ll end up in roughly the same place.
Vaginal Symptoms Are a Separate Category
One important distinction: vaginal dryness, irritation, and urinary symptoms (collectively called genitourinary syndrome of menopause) behave differently from hot flashes. These symptoms tend to get worse over time rather than better, and they don’t resolve on their own. The Menopause Society’s position is that low-dose vaginal estrogen can be used at any age and for as long as needed, because the systemic absorption is minimal and the risks are very low.
If you stop systemic HRT but still have vaginal or urinary symptoms, switching to a local vaginal treatment is a common and well-supported approach. Options include vaginal estrogen in cream, ring, or tablet form, as well as non-estrogen alternatives like vaginal DHEA inserts. These are considered safe even for many women who can’t use systemic hormones, though women with a history of hormone-sensitive cancers should discuss the options carefully with their oncologist.
Making the Decision Personal
The question of when to stop HRT isn’t really one question. It’s a series of smaller ones: Are your original symptoms still present? Has your health profile changed? What type and dose are you on? What are you most concerned about, cancer risk, bone loss, heart health, or quality of life? The answers to those questions will look different for a 55-year-old five years into therapy than for a 68-year-old who’s been on a low-dose patch for 15 years.
A reasonable approach is to revisit the decision every year or two with your provider, especially after age 60. If you’re still getting meaningful symptom relief and your risk factors remain favorable, continuing is a legitimate choice. If your symptoms have faded and you’re mainly staying on HRT out of habit or fear of what stopping will feel like, a trial discontinuation with close follow-up can give you real information to work with.